Therdose Pharma Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2003.
2003 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Therdose Pharma Private Limited

Therdose Pharma Private Limited, a active private limited company, was established on 19 December 2003 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24239TG2003PTC042272. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹9.99 Cr.

Formerly known as Oshadha Therapeutics Private Limited. It upholds a compliant status. Employing 137 professional, Its leadership includes Meka Kesava Sambasiva Rao (Director), Narayana Raju Mantana (Director), Arvind Reddy Panyala (Director). Past directors included Meka Kesava Sambasiva Rao, Palepu Bharathy, Narayana Raju Mantana. It holds ₹11.58 Cr open charges and ₹24.13 Cr settled loans. Its latest AGM occurred on 29 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.118, 119 & 120, Survey No.342, Aleap Industrialestate,Opp:Jntu,Pragati Nagar,, Kukatpally, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2003PTC042272

  • Registration Number

    042272

  • Incorporation Date

    19 December 2003

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹9.99 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 9.99 Cr
  • Company Age 22 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 11.58 Cr
  • Satisfied Charges ₹ 24.13 Cr
  • Revenue Growth **** -16.17%
  • Profit Growth **** -93.73%
  • Ebitda **** -69.24%
  • Net Worth 5.69%
  • Total Assets **** 9.76%
Company report

Therdose Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Therdose Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Therdose Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Meka Kesava Sambasiva Rao Director 26 Nov 2021 Current
Narayana Raju Mantana Director 15 Apr 2024 Current
Arvind Reddy Panyala Director 26 Nov 2021 Current
Mahindra Dev Imadabathuni Whole-Time Director 26 Nov 2021 Current
Raja Vakula Devi Imadabathuni Director 03 Oct 2022 Current
Ratna Sekhar Rao Imadabathuni Managing Director 12 Nov 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Nov 2021 Past
Pramod Abcsdd Director 09 Jan 2019 Past
Pramod Abcsdd Additional Director 28 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Nov 2021 Past
Pramod Abcsdd Additional Director 29 Nov 2021 Past
Pramod Abcsdd Director 09 Jan 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Therdose Pharma.

Therdose Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.17% decrease. The company also saw a substantial fall in profitability, with a 93.73% decrease in profit. The company's net worth moved up by a moderate rise of 5.69%.

Therdose Pharma revenue growth over time
Therdose Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -16.17%
*******
*******
*******
*******
Revenue from Operations
*******
 -16.17%
*******
*******
*******
*******
Total Assets
*******
 9.76%
*******
*******
*******
*******
Profit or Loss
*******
 -93.73%
*******
*******
*******
*******
Net Worth
*******
 5.69%
*******
*******
*******
*******
EBITDA
*******
 -69.24%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Therdose Pharma?

In 2023, Therdose Pharma had a promoter holding of 51.06% and a public holding of 48.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹115,780,000.00

Satisfied Charges

₹241,343,000.00

Charges Breakdown by Lending Institutions
  • Others : 11.58 Cr
Latest Charge Details
Date Lender Amount Status
08 Dec 2022 Others ₹11.58 Cr Open
06 May 2022 Axis Bank Limited ₹2.57 M Satisfied
31 Jul 2018 Others ₹5.88 M Satisfied
31 Jul 2015 Reliance Capital Ltd ₹7.40 M Satisfied
21 Mar 2012 Others ₹12.65 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Therdose Pharma?

Therdose Pharma has a workforce of 137 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Therdose Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Therdose Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Therdose Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Therdose Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records. was documented.

  • Director Appointment

    The activity Narayana Raju Mantana was appointed as a Director was appointed as a Director on 15 Apr 2024 & has been associated with this company since 1 year 10 months . was completed.

  • Balance Sheet

    Therdose Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 11.58 Cr registered on 08 Dec 2022 with Charge ID 100660592 was modified on 19 Dec 2023. was recorded as a recent event.

  • Charges

    The activity A charge registered on 06 May 2022 via Charge ID 100577114 with Axis Bank Limited was fully satisfied on 10 May 2023. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 11.58 Cr with Charge ID 100660592 was registered on 08 Dec 2022. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Therdose Pharma Private Limited?

The CIN of Therdose Pharma Private Limited is U24239TG2003PTC042272.

Where is Therdose Pharma Private Limited headquartered?

Therdose Pharma Private Limited is headquartered at Plot No.118, 119 & 120, Survey No.342, Aleap Industrialestate,Opp:Jntu,Pragati Nagar,, Kukatpally, Hyderabad, Telangana, 500072.

When was Therdose Pharma Private Limited incorporated?

Therdose Pharma Private Limited was incorporated on 19 December 2003.

Who are the current directors of Therdose Pharma Private Limited?

The current directors of Therdose Pharma Private Limited are

What is the primary industry of Therdose Pharma Private Limited?

The primary industry of Therdose Pharma Private Limited is Professional, Scientific And Technical.

Is Therdose Pharma Private Limited a listed company?

Therdose Pharma Private Limited is unlisted.

What is the capital structure of Therdose Pharma Private Limited?

The authorized capital of Therdose Pharma Private Limited is ₹10.00 Cr, and the paid-up capital is ₹9.99 Cr.

What is the compliance status of Therdose Pharma Private Limited?

The compliance status of Therdose Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available